DiaMedica Therapeutics Inc.

DMAC ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
144 Jul 2, 2024
4 Jul 1, 2024 OWNERSHIP DOCUMENT
4 Jul 1, 2024 OWNERSHIP DOCUMENT
8-K Jun 26, 2024 FORM 8-K
8-K Jun 26, 2024 FORM 8-K
4 Jun 3, 2024 PRIMARY DOCUMENT
4 Jun 3, 2024 PRIMARY DOCUMENT
4 Jun 3, 2024 PRIMARY DOCUMENT
4 Jun 3, 2024 PRIMARY DOCUMENT
4 Jun 3, 2024 PRIMARY DOCUMENT
4 Jun 3, 2024 PRIMARY DOCUMENT
4 Jun 3, 2024 PRIMARY DOCUMENT
4 Jun 3, 2024 PRIMARY DOCUMENT
4 Jun 3, 2024 PRIMARY DOCUMENT
4 Jun 3, 2024 PRIMARY DOCUMENT
S-8 May 24, 2024 FORM S-8
8-K May 23, 2024 FORM 8-K
10-Q May 8, 2024 FORM 10-Q
8-K May 8, 2024 FORM 8-K
8-K Apr 10, 2024 FORM 8-K
EFFECT Apr 9, 2024
CORRESP Apr 4, 2024
ARS Apr 4, 2024 ARS
DEFA14A Apr 4, 2024 FORM DEFA14A
DEF 14A Apr 4, 2024 FORM DEF 14A
← Newer Page 5 of 18 · 427 filings Older →